Systemic Immunity Is Required for Effective Cancer Immunotherapy (Q39006805)

30 May 2018

title

Systemic Immunity Is Required for Effective Cancer Immunotherapy (English)

1 reference

30 May 2018

1 reference

Nathan E Reticker-Flynn

object named as

Nathan E Reticker-Flynn

3

0 references

Pier Federico Gherardini

7

object named as

Pier Federico Gherardini

1 reference

30 May 2018

0 references

12

Garry P Nolan

1 reference

30 May 2018

author name string

Matthew H Spitzer

1

1 reference

30 May 2018

Yaron Carmi

2

1 reference

30 May 2018

Serena S Kwek

4

1 reference

30 May 2018

Deepthi Madhireddy

5

1 reference

30 May 2018

Maria M Martins

6

1 reference

30 May 2018

Tyler R Prestwood

8

1 reference

30 May 2018

Jonathan Chabon

9

1 reference

30 May 2018

Sean C Bendall

10

1 reference

30 May 2018

Lawrence Fong

11

1 reference

30 May 2018

Edgar G Engleman

13

1 reference

30 May 2018

language of work or name

English

0 references

publication date

19 January 2017

1 reference

30 May 2018

published in

Cell

1 reference

30 May 2018

volume

168

1 reference

30 May 2018

issue

3

1 reference

30 May 2018

page(s)

487-502.e15

1 reference

30 May 2018

describes a project that uses

1 reference

10 June 2022

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&rettype=xml&id=5312823

cites work

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

IMMUNOLOGY. An interactive reference framework for modeling a dynamic immune system

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

T-cell exhaustion in the tumor microenvironment

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Immune checkpoint blockade: a common denominator approach to cancer therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Automated identification of stratifying signatures in cellular subpopulations

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Oncology meets immunology: the cancer-immunity cycle

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Normalization of mass cytometry data with bead standards

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Adoptive immunotherapy for cancer: harnessing the T cell response

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Coordinated regulation of myeloid cells by tumours

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Expanding roles for CD4⁺ T cells in immunity to viruses.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Ly6C supports preferential homing of central memory CD8+ T cells into lymph nodes

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Plasma cells negatively regulate the follicular helper T cell program

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Thy-1: more than a mouse pan-T cell marker

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Semi-supervised methods to predict patient survival from gene expression data

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312823

Decade in review-cancer immunotherapy: entering the mainstream of cancer treatment

2 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28111070

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28111070

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CELL.2016.12.022

1 reference

30 May 2018

PMC publication ID

5312823

1 reference

30 May 2018

PubMed publication ID

28111070

1 reference

30 May 2018